| Similar Articles |
|---|
 |
Chemistry World
December 9, 2011
Jennifer Newton |
Turning Bacteria's Shield Into a Weapon Against it Scientists in Germany have synthesised the core part of a sugar compound produced by the pathogenic bacteria responsible for meningitis - Neisseria meningitides - which could be used in a vaccine for meningococcal diseases, in particular meningitis B.   |
Chemistry World
September 2, 2007
Simon Hadlington |
Sweet Approach to Tackling Cancer A promising new 'slimline' cancer vaccine that triggers a powerful immune response against excessive sugar molecules has been unveiled by researchers. |
Chemistry World
August 18, 2011
Helen Bache |
Sugar injection to beat hospital infection A carbohydrate from the surface of the most virulent strain of the bacterium Clostridium difficile has been synthesised by chemists in Germany. The molecule could be used to develop a vaccine against the infection. |
Chemistry World
January 17, 2010
Simon Hadlington |
Sugars synthesised with help of promiscuous enzyme European researchers have discovered a new way to make synthetically elusive sugar molecules that could lead to novel vaccine candidates and other medically important compounds. |
Chemistry World
February 5, 2014
Jenifer Mizen |
Protein-free and low sugar -- not a new diet, a new vaccine A Streptococcus pneumonia vaccine with fewer sugar units and no antigenic protein is not only easier to produce but could also induce a superior immune response to the vaccine currently in clinical use. |
Reactive Reports
Issue 58 |
Anthrax Detector Researchers have developed a detector for anthrax spores based on a monoclonal antibody that recognizes a specific sugar on the bacterium. It might be possible to use this discovery to develop a passive immunization method. |
Chemistry World
January 22, 2014
Eleanor Merritt |
Designer esters for complex carbohydrates Scientists based in the US have developed a new strategy to simplify the chemical synthesis of complex carbohydrates. |
Wired
June 2001 |
Verge Automated Oligosaccharide Synthesizer can produce a polymer composed of 12 monosaccharides in about 18 hours - almost a hundred times faster than other methods... |
Chemistry World
January 20, 2012
Andy Extance |
Tube-wrapped lamp makes malaria drug German researchers have developed an inexpensive three-step continuous flow synthesis of artemisinin, the key drug in the ongoing fight against malaria. |
Chemistry World
July 27, 2012
Samantha Cheung |
A sweeter approach to sugar synthesis Sugar chemists have developed a highly efficient synthetic pathway to produce a variety of oligosaccharides from scratch. |
Chemistry World
March 3, 2009
Lewis Brindley |
Sweet-toothed bacteria make their own vaccine With careful feeding, bacteria can produce vaccines against themselves, scientists in the US and China have found. |
Chemistry World
March 8, 2006
Simon Hadlington |
New Route to C-Glycoside Creation Overcomes Earlier Drawbacks A one-pot process for creating C-glycosides could help prepare robust analogues of naturally occurring carbohydrates. The technique could ultimately be used to make carbohydrate derivatives more widely available for use in applications from drugs to biosensors. |
Chemistry World
September 26, 2007
Victoria Gill |
HIV Vaccines 'Will Not Work' Just days after US drug firm Merck revealed its leading HIV vaccine candidate had flopped in clinical trials, a leading immunologist has predicted that many other vaccines in the pipeline will also fail because their design is similarly flawed. |
Chemistry World
December 15, 2015
Michaela Muehlberg |
Bacterial identification gets a culture shock Scientists in the UK have developed a new tool to distinguish bacterial strains from each other. |
Reactive Reports
Issue 75
David Bradley |
Chasing Down Mad Cows Researchers in Europe have tracked down the molecular anchor that hooks errant and infectious prions leading to mad cow disease in sheep. |
Chemistry World
April 17, 2013
Mark Peplow |
Sanofi launches malaria drug production On 11 April, the Paris-based pharmaceutical company Sanofi officially launched a new production facility in Garessio, Italy, to make artemisinin -- the precursor to artemisinin-based combination therapies, the most effective drugs against the deadliest malaria parasite. |
Chemistry World
September 10, 2014
Elisabeth Ratcliffe |
Antimalarial flow synthesis closer to commercialization Scientists in Germany have demonstrated the large scale and inexpensive production of a range of antimalarial drugs, using a continuous flow system. |
Chemistry World
July 2008
Mark Peplow |
Editorial: There's plenty of room in the middle Today, chemists and biologists are looking at the space between their own disciplines and asking big questions about where science at the interface might lead them. |
BusinessWeek
October 22, 2007
Catherine Arnst |
Roll Up Your Sleeve, Gramps A graying population may create a huge market for vaccines that buttress aging immune systems. |
The Motley Fool
December 30, 2008
Brian Orelli |
A Shot in the Arm for Novartis' Pipeline The company picks up the rights to a vaccine that fights a virus. |
BusinessWeek
October 25, 2004
John Carey |
A Booster Shot For Vaccines New technology could speed the development of vaccines and keep the medicine chest stocked. |
Chemistry World
January 19, 2015
Maria Burke |
Roadmap to fast track Ebola vaccine development A global group of experts has developed a 'roadmap' to help the health community fast track an Ebola vaccine. |
American Family Physician
July 1, 2004 |
Travel Vaccines An informative brochure on the importance of travel vaccines and procedures regarding their use. |
HBS Working Knowledge
March 1, 2004
Martha Lagace |
Injecting New Life into the Vaccine Industry Vaccines for preventable diseases save millions of lives every year, yet as an industry, the vaccine business suffers a host of ailments, the CEO of Merck & Co. contends. |
